nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—NR3C2—collecting duct of renal tubule—kidney cancer	0.112	0.379	CbGeAlD
Fludrocortisone—NR3C2—nephron—kidney cancer	0.05	0.169	CbGeAlD
Fludrocortisone—NR3C1—urine—kidney cancer	0.0215	0.0725	CbGeAlD
Fludrocortisone—NR3C2—nephron tubule—kidney cancer	0.0108	0.0364	CbGeAlD
Fludrocortisone—NR3C2—renal system—kidney cancer	0.00981	0.0331	CbGeAlD
Fludrocortisone—NR3C2—kidney—kidney cancer	0.00948	0.032	CbGeAlD
Fludrocortisone—NR3C2—cortex of kidney—kidney cancer	0.00924	0.0311	CbGeAlD
Fludrocortisone—NR3C2—cardiac atrium—kidney cancer	0.00879	0.0296	CbGeAlD
Fludrocortisone—AR—renal system—kidney cancer	0.00726	0.0245	CbGeAlD
Fludrocortisone—AR—kidney—kidney cancer	0.00702	0.0237	CbGeAlD
Fludrocortisone—AR—cortex of kidney—kidney cancer	0.00684	0.0231	CbGeAlD
Fludrocortisone—AR—gonad—kidney cancer	0.00651	0.022	CbGeAlD
Fludrocortisone—AR—cardiac atrium—kidney cancer	0.00651	0.0219	CbGeAlD
Fludrocortisone—Amcinonide—ANXA1—kidney cancer	0.00595	0.317	CrCbGaD
Fludrocortisone—NR3C1—nephron tubule—kidney cancer	0.00579	0.0195	CbGeAlD
Fludrocortisone—NR3C1—renal system—kidney cancer	0.00526	0.0177	CbGeAlD
Fludrocortisone—NR3C1—kidney—kidney cancer	0.00509	0.0172	CbGeAlD
Fludrocortisone—NR3C1—cortex of kidney—kidney cancer	0.00495	0.0167	CbGeAlD
Fludrocortisone—NR3C1—gonad—kidney cancer	0.00472	0.0159	CbGeAlD
Fludrocortisone—NR3C1—cardiac atrium—kidney cancer	0.00471	0.0159	CbGeAlD
Fludrocortisone—Diabetes mellitus—Everolimus—kidney cancer	0.00334	0.0056	CcSEcCtD
Fludrocortisone—Petechiae—Gemcitabine—kidney cancer	0.00326	0.00547	CcSEcCtD
Fludrocortisone—Cardiomegaly—Doxorubicin—kidney cancer	0.00326	0.00546	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CITED1—kidney cancer	0.00323	0.0368	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Everolimus—kidney cancer	0.00321	0.00537	CcSEcCtD
Fludrocortisone—Abdominal distension—Pazopanib—kidney cancer	0.0032	0.00537	CcSEcCtD
Fludrocortisone—Hirsutism—Capecitabine—kidney cancer	0.00317	0.00532	CcSEcCtD
Fludrocortisone—Neoplasm—Sorafenib—kidney cancer	0.00314	0.00527	CcSEcCtD
Fludrocortisone—Pancreatitis—Pazopanib—kidney cancer	0.00312	0.00523	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Capecitabine—kidney cancer	0.0031	0.00519	CcSEcCtD
Fludrocortisone—Oesophagitis—Sunitinib—kidney cancer	0.00306	0.00512	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Temsirolimus—kidney cancer	0.00305	0.00511	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Sunitinib—kidney cancer	0.00304	0.00509	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Paclitaxel—kidney cancer	0.00304	0.00509	CcSEcCtD
Fludrocortisone—Neoplasm—Sunitinib—kidney cancer	0.00302	0.00507	CcSEcCtD
Fludrocortisone—Oesophagitis—Dactinomycin—kidney cancer	0.00289	0.00485	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Sorafenib—kidney cancer	0.00278	0.00466	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Sunitinib—kidney cancer	0.00268	0.00449	CcSEcCtD
Fludrocortisone—Contusion—Paclitaxel—kidney cancer	0.00258	0.00432	CcSEcCtD
Fludrocortisone—Muscular weakness—Everolimus—kidney cancer	0.00256	0.0043	CcSEcCtD
Fludrocortisone—Haemoglobin—Pazopanib—kidney cancer	0.00256	0.00429	CcSEcCtD
Fludrocortisone—Fluid retention—Gemcitabine—kidney cancer	0.00255	0.00427	CcSEcCtD
Fludrocortisone—Haemorrhage—Pazopanib—kidney cancer	0.00255	0.00427	CcSEcCtD
Fludrocortisone—Abdominal distension—Everolimus—kidney cancer	0.00253	0.00424	CcSEcCtD
Fludrocortisone—Hydrocortisone—ANXA1—kidney cancer	0.00251	0.134	CrCbGaD
Fludrocortisone—Pancreatitis—Everolimus—kidney cancer	0.00246	0.00413	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CITED1—kidney cancer	0.00245	0.0279	CbGpPWpGaD
Fludrocortisone—Mood swings—Sorafenib—kidney cancer	0.00239	0.00401	CcSEcCtD
Fludrocortisone—Pancreatitis—Erlotinib—kidney cancer	0.00238	0.00398	CcSEcCtD
Fludrocortisone—Erythema—Temsirolimus—kidney cancer	0.00235	0.00394	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—TFE3—kidney cancer	0.00233	0.0266	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Everolimus—kidney cancer	0.00227	0.0038	CcSEcCtD
Fludrocortisone—Hypernatraemia—Doxorubicin—kidney cancer	0.00226	0.00379	CcSEcCtD
Fludrocortisone—NR3C2—Preimplantation Embryo—EGR1—kidney cancer	0.00226	0.0257	CbGpPWpGaD
Fludrocortisone—Petechiae—Capecitabine—kidney cancer	0.00224	0.00376	CcSEcCtD
Fludrocortisone—Erythema—Pazopanib—kidney cancer	0.00222	0.00372	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF1A—kidney cancer	0.00219	0.0249	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Gemcitabine—kidney cancer	0.00215	0.0036	CcSEcCtD
Fludrocortisone—Muscular weakness—Sunitinib—kidney cancer	0.00214	0.00359	CcSEcCtD
Fludrocortisone—Pancreatitis—Sorafenib—kidney cancer	0.00214	0.00358	CcSEcCtD
Fludrocortisone—Fluid retention—Paclitaxel—kidney cancer	0.00213	0.00357	CcSEcCtD
Fludrocortisone—Contusion—Capecitabine—kidney cancer	0.00211	0.00354	CcSEcCtD
Fludrocortisone—Abdominal distension—Sunitinib—kidney cancer	0.00211	0.00354	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—FOSL2—kidney cancer	0.00209	0.0238	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Sunitinib—kidney cancer	0.00206	0.00345	CcSEcCtD
Fludrocortisone—Oesophagitis—Paclitaxel—kidney cancer	0.00205	0.00344	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Paclitaxel—kidney cancer	0.00204	0.00342	CcSEcCtD
Fludrocortisone—Convulsion—Temsirolimus—kidney cancer	0.00204	0.00342	CcSEcCtD
Fludrocortisone—Hypertension—Temsirolimus—kidney cancer	0.00203	0.0034	CcSEcCtD
Fludrocortisone—Neoplasm—Paclitaxel—kidney cancer	0.00203	0.0034	CcSEcCtD
Fludrocortisone—Haemoglobin—Vinblastine—kidney cancer	0.00203	0.0034	CcSEcCtD
Fludrocortisone—Haemoglobin—Everolimus—kidney cancer	0.00202	0.00339	CcSEcCtD
Fludrocortisone—Haemorrhage—Vinblastine—kidney cancer	0.00202	0.00338	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Gemcitabine—kidney cancer	0.00201	0.00337	CcSEcCtD
Fludrocortisone—Haemorrhage—Everolimus—kidney cancer	0.00201	0.00337	CcSEcCtD
Fludrocortisone—Myalgia—Temsirolimus—kidney cancer	0.002	0.00336	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Doxorubicin—kidney cancer	0.002	0.00335	CcSEcCtD
Fludrocortisone—Haemoglobin—Erlotinib—kidney cancer	0.00195	0.00327	CcSEcCtD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—kidney cancer	0.00194	0.0221	CbGpPWpGaD
Fludrocortisone—Haemorrhage—Erlotinib—kidney cancer	0.00194	0.00325	CcSEcCtD
Fludrocortisone—Cataract—Capecitabine—kidney cancer	0.00194	0.00325	CcSEcCtD
Fludrocortisone—Optic neuritis—Doxorubicin—kidney cancer	0.00193	0.00324	CcSEcCtD
Fludrocortisone—Oedema—Temsirolimus—kidney cancer	0.00192	0.00322	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Temsirolimus—kidney cancer	0.00192	0.00322	CcSEcCtD
Fludrocortisone—Hypertension—Pazopanib—kidney cancer	0.00191	0.00321	CcSEcCtD
Fludrocortisone—Infection—Temsirolimus—kidney cancer	0.00191	0.0032	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Sunitinib—kidney cancer	0.00189	0.00317	CcSEcCtD
Fludrocortisone—Myalgia—Pazopanib—kidney cancer	0.00189	0.00316	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Paclitaxel—kidney cancer	0.00188	0.00316	CcSEcCtD
Fludrocortisone—Dexamethasone—ANXA1—kidney cancer	0.00187	0.0996	CrCbGaD
Fludrocortisone—Muscular weakness—Vincristine—kidney cancer	0.00181	0.00304	CcSEcCtD
Fludrocortisone—Oedema—Pazopanib—kidney cancer	0.00181	0.00303	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Paclitaxel—kidney cancer	0.0018	0.00301	CcSEcCtD
Fludrocortisone—Infection—Pazopanib—kidney cancer	0.0018	0.00301	CcSEcCtD
Fludrocortisone—Injury—Paclitaxel—kidney cancer	0.00177	0.00297	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—TFE3—kidney cancer	0.00177	0.0202	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Sorafenib—kidney cancer	0.00175	0.00294	CcSEcCtD
Fludrocortisone—Fluid retention—Capecitabine—kidney cancer	0.00175	0.00293	CcSEcCtD
Fludrocortisone—Erythema—Everolimus—kidney cancer	0.00175	0.00293	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Temsirolimus—kidney cancer	0.00175	0.00293	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Pazopanib—kidney cancer	0.00175	0.00293	CcSEcCtD
Fludrocortisone—Haemorrhage—Sorafenib—kidney cancer	0.00175	0.00293	CcSEcCtD
Fludrocortisone—Insomnia—Temsirolimus—kidney cancer	0.00174	0.00291	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—CER1—kidney cancer	0.00171	0.0194	CbGpPWpGaD
Fludrocortisone—Erythema—Erlotinib—kidney cancer	0.00169	0.00283	CcSEcCtD
Fludrocortisone—Haemoglobin—Sunitinib—kidney cancer	0.00169	0.00283	CcSEcCtD
Fludrocortisone—Oesophagitis—Capecitabine—kidney cancer	0.00169	0.00282	CcSEcCtD
Fludrocortisone—Haemorrhage—Sunitinib—kidney cancer	0.00168	0.00281	CcSEcCtD
Fludrocortisone—Neoplasm—Capecitabine—kidney cancer	0.00167	0.00279	CcSEcCtD
Fludrocortisone—Ecchymosis—Capecitabine—kidney cancer	0.00167	0.00279	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Pazopanib—kidney cancer	0.00165	0.00276	CcSEcCtD
Fludrocortisone—Insomnia—Pazopanib—kidney cancer	0.00164	0.00274	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Doxorubicin—kidney cancer	0.00161	0.00269	CcSEcCtD
Fludrocortisone—Vertigo—Vinblastine—kidney cancer	0.00158	0.00265	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Capecitabine—kidney cancer	0.00155	0.00259	CcSEcCtD
Fludrocortisone—Mood swings—Paclitaxel—kidney cancer	0.00155	0.00259	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Capecitabine—kidney cancer	0.00154	0.00258	CcSEcCtD
Fludrocortisone—Convulsion—Vinblastine—kidney cancer	0.00152	0.00255	CcSEcCtD
Fludrocortisone—Erythema—Sorafenib—kidney cancer	0.00152	0.00255	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Gemcitabine—kidney cancer	0.00152	0.00255	CcSEcCtD
Fludrocortisone—Hypertension—Vinblastine—kidney cancer	0.00152	0.00254	CcSEcCtD
Fludrocortisone—Convulsion—Everolimus—kidney cancer	0.00152	0.00254	CcSEcCtD
Fludrocortisone—Hypertension—Everolimus—kidney cancer	0.00151	0.00253	CcSEcCtD
Fludrocortisone—Vascular purpura—Capecitabine—kidney cancer	0.0015	0.00251	CcSEcCtD
Fludrocortisone—Myalgia—Everolimus—kidney cancer	0.00149	0.0025	CcSEcCtD
Fludrocortisone—Glycosuria—Doxorubicin—kidney cancer	0.00147	0.00246	CcSEcCtD
Fludrocortisone—Erythema—Sunitinib—kidney cancer	0.00146	0.00245	CcSEcCtD
Fludrocortisone—Petechiae—Doxorubicin—kidney cancer	0.00145	0.00242	CcSEcCtD
Fludrocortisone—Muscular weakness—Paclitaxel—kidney cancer	0.00144	0.00241	CcSEcCtD
Fludrocortisone—Myalgia—Erlotinib—kidney cancer	0.00144	0.00241	CcSEcCtD
Fludrocortisone—Oedema—Everolimus—kidney cancer	0.00143	0.00239	CcSEcCtD
Fludrocortisone—Infection—Everolimus—kidney cancer	0.00142	0.00238	CcSEcCtD
Fludrocortisone—Abdominal distension—Paclitaxel—kidney cancer	0.00142	0.00238	CcSEcCtD
Fludrocortisone—Hypersensitivity—Temsirolimus—kidney cancer	0.00142	0.00237	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—FOSL1—kidney cancer	0.00139	0.0159	CbGpPWpGaD
Fludrocortisone—Purpura—Capecitabine—kidney cancer	0.00139	0.00233	CcSEcCtD
Fludrocortisone—Erythema—Dactinomycin—kidney cancer	0.00138	0.00232	CcSEcCtD
Fludrocortisone—Pancreatitis—Paclitaxel—kidney cancer	0.00138	0.00232	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Everolimus—kidney cancer	0.00138	0.00231	CcSEcCtD
Fludrocortisone—Oedema—Erlotinib—kidney cancer	0.00138	0.00231	CcSEcCtD
Fludrocortisone—Asthenia—Temsirolimus—kidney cancer	0.00138	0.00231	CcSEcCtD
Fludrocortisone—Sweating increased—Paclitaxel—kidney cancer	0.00137	0.0023	CcSEcCtD
Fludrocortisone—Infection—Erlotinib—kidney cancer	0.00137	0.00229	CcSEcCtD
Fludrocortisone—Haemoglobin—Gemcitabine—kidney cancer	0.00135	0.00227	CcSEcCtD
Fludrocortisone—Amenorrhoea—Doxorubicin—kidney cancer	0.00135	0.00227	CcSEcCtD
Fludrocortisone—Haemorrhage—Gemcitabine—kidney cancer	0.00135	0.00226	CcSEcCtD
Fludrocortisone—Hypertension—Sorafenib—kidney cancer	0.00131	0.0022	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Everolimus—kidney cancer	0.0013	0.00218	CcSEcCtD
Fludrocortisone—Asthenia—Pazopanib—kidney cancer	0.0013	0.00218	CcSEcCtD
Fludrocortisone—Myalgia—Sorafenib—kidney cancer	0.00129	0.00217	CcSEcCtD
Fludrocortisone—Insomnia—Everolimus—kidney cancer	0.00129	0.00217	CcSEcCtD
Fludrocortisone—NR3C2—Preimplantation Embryo—CDH1—kidney cancer	0.00127	0.0145	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Paclitaxel—kidney cancer	0.00127	0.00213	CcSEcCtD
Fludrocortisone—Mood swings—Capecitabine—kidney cancer	0.00127	0.00212	CcSEcCtD
Fludrocortisone—Convulsion—Sunitinib—kidney cancer	0.00127	0.00212	CcSEcCtD
Fludrocortisone—Hypertension—Sunitinib—kidney cancer	0.00126	0.00212	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—HNF1B—kidney cancer	0.00126	0.0143	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—BMP7—kidney cancer	0.00126	0.0143	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00126	0.0021	CcSEcCtD
Fludrocortisone—Insomnia—Erlotinib—kidney cancer	0.00125	0.00209	CcSEcCtD
Fludrocortisone—Myalgia—Sunitinib—kidney cancer	0.00125	0.00209	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Sorafenib—kidney cancer	0.00124	0.00208	CcSEcCtD
Fludrocortisone—Infection—Sorafenib—kidney cancer	0.00123	0.00206	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MITF—kidney cancer	0.00121	0.0137	CbGpPWpGaD
Fludrocortisone—Headache—Temsirolimus—kidney cancer	0.0012	0.00202	CcSEcCtD
Fludrocortisone—Oedema—Sunitinib—kidney cancer	0.00119	0.002	CcSEcCtD
Fludrocortisone—Infection—Sunitinib—kidney cancer	0.00119	0.00199	CcSEcCtD
Fludrocortisone—Muscular weakness—Capecitabine—kidney cancer	0.00118	0.00198	CcSEcCtD
Fludrocortisone—Myalgia—Dactinomycin—kidney cancer	0.00118	0.00197	CcSEcCtD
Fludrocortisone—Erythema—Gemcitabine—kidney cancer	0.00117	0.00197	CcSEcCtD
Fludrocortisone—Abdominal distension—Capecitabine—kidney cancer	0.00116	0.00195	CcSEcCtD
Fludrocortisone—Triamcinolone—BCHE—kidney cancer	0.00114	0.0609	CrCbGaD
Fludrocortisone—Haemoglobin—Paclitaxel—kidney cancer	0.00113	0.0019	CcSEcCtD
Fludrocortisone—Headache—Pazopanib—kidney cancer	0.00113	0.0019	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00113	0.00189	CcSEcCtD
Fludrocortisone—Oedema—Dactinomycin—kidney cancer	0.00113	0.00189	CcSEcCtD
Fludrocortisone—Fluid retention—Doxorubicin—kidney cancer	0.00113	0.00189	CcSEcCtD
Fludrocortisone—Haemorrhage—Paclitaxel—kidney cancer	0.00113	0.00189	CcSEcCtD
Fludrocortisone—Sweating increased—Capecitabine—kidney cancer	0.00113	0.00189	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—EGR1—kidney cancer	0.00113	0.0128	CbGpPWpGaD
Fludrocortisone—Infection—Dactinomycin—kidney cancer	0.00112	0.00188	CcSEcCtD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—kidney cancer	0.00112	0.0127	CbGpPWpGaD
Fludrocortisone—Vertigo—Vincristine—kidney cancer	0.00111	0.00186	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00109	0.00182	CcSEcCtD
Fludrocortisone—Oesophagitis—Doxorubicin—kidney cancer	0.00109	0.00182	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Doxorubicin—kidney cancer	0.00108	0.00181	CcSEcCtD
Fludrocortisone—Insomnia—Sunitinib—kidney cancer	0.00108	0.00181	CcSEcCtD
Fludrocortisone—Ecchymosis—Doxorubicin—kidney cancer	0.00107	0.0018	CcSEcCtD
Fludrocortisone—Neoplasm—Doxorubicin—kidney cancer	0.00107	0.0018	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—JUND—kidney cancer	0.00107	0.0122	CbGpPWpGaD
Fludrocortisone—Clobetasol propionate—CYP1A1—kidney cancer	0.00107	0.0572	CrCbGaD
Fludrocortisone—Convulsion—Vincristine—kidney cancer	0.00107	0.0018	CcSEcCtD
Fludrocortisone—Hypertension—Vincristine—kidney cancer	0.00107	0.00179	CcSEcCtD
Fludrocortisone—Hypersensitivity—Vinblastine—kidney cancer	0.00106	0.00177	CcSEcCtD
Fludrocortisone—Myalgia—Vincristine—kidney cancer	0.00105	0.00176	CcSEcCtD
Fludrocortisone—Hypersensitivity—Everolimus—kidney cancer	0.00105	0.00176	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Capecitabine—kidney cancer	0.00104	0.00175	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00103	0.00172	CcSEcCtD
Fludrocortisone—Asthenia—Vinblastine—kidney cancer	0.00103	0.00172	CcSEcCtD
Fludrocortisone—Asthenia—Everolimus—kidney cancer	0.00103	0.00172	CcSEcCtD
Fludrocortisone—Hypertension—Gemcitabine—kidney cancer	0.00101	0.0017	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Vincristine—kidney cancer	0.00101	0.00169	CcSEcCtD
Fludrocortisone—Oedema—Vincristine—kidney cancer	0.00101	0.00169	CcSEcCtD
Fludrocortisone—Infection—Vincristine—kidney cancer	0.001	0.00168	CcSEcCtD
Fludrocortisone—Myalgia—Gemcitabine—kidney cancer	0.000999	0.00167	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Doxorubicin—kidney cancer	0.000997	0.00167	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Doxorubicin—kidney cancer	0.000992	0.00166	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—FOSL1—kidney cancer	0.000992	0.0113	CbGpPWpGaD
Fludrocortisone—Asthenia—Erlotinib—kidney cancer	0.000989	0.00166	CcSEcCtD
Fludrocortisone—Urticaria—Sorafenib—kidney cancer	0.000985	0.00165	CcSEcCtD
Fludrocortisone—Erythema—Paclitaxel—kidney cancer	0.000982	0.00165	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Vincristine—kidney cancer	0.000976	0.00164	CcSEcCtD
Fludrocortisone—Vascular purpura—Doxorubicin—kidney cancer	0.000965	0.00162	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Gemcitabine—kidney cancer	0.000958	0.0016	CcSEcCtD
Fludrocortisone—Oedema—Gemcitabine—kidney cancer	0.000958	0.0016	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000952	0.00159	CcSEcCtD
Fludrocortisone—Infection—Gemcitabine—kidney cancer	0.000951	0.00159	CcSEcCtD
Fludrocortisone—Haemoglobin—Capecitabine—kidney cancer	0.000931	0.00156	CcSEcCtD
Fludrocortisone—Haemorrhage—Capecitabine—kidney cancer	0.000926	0.00155	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Gemcitabine—kidney cancer	0.000926	0.00155	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00092	0.00154	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—EPAS1—kidney cancer	0.000919	0.0105	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—HNF1A—kidney cancer	0.000919	0.0105	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Sorafenib—kidney cancer	0.000914	0.00153	CcSEcCtD
Fludrocortisone—Insomnia—Vincristine—kidney cancer	0.000913	0.00153	CcSEcCtD
Fludrocortisone—Headache—Vinblastine—kidney cancer	0.000899	0.00151	CcSEcCtD
Fludrocortisone—Purpura—Doxorubicin—kidney cancer	0.000895	0.0015	CcSEcCtD
Fludrocortisone—Headache—Everolimus—kidney cancer	0.000895	0.0015	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000892	0.00149	CcSEcCtD
Fludrocortisone—Asthenia—Sorafenib—kidney cancer	0.00089	0.00149	CcSEcCtD
Fludrocortisone—Vertigo—Paclitaxel—kidney cancer	0.000883	0.00148	CcSEcCtD
Fludrocortisone—Hypersensitivity—Sunitinib—kidney cancer	0.000879	0.00147	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000873	0.00146	CcSEcCtD
Fludrocortisone—Insomnia—Gemcitabine—kidney cancer	0.000866	0.00145	CcSEcCtD
Fludrocortisone—Headache—Erlotinib—kidney cancer	0.000864	0.00145	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—HIF1A—kidney cancer	0.000863	0.00982	CbGpPWpGaD
Fludrocortisone—Asthenia—Sunitinib—kidney cancer	0.000856	0.00143	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—EGR1—kidney cancer	0.000854	0.00973	CbGpPWpGaD
Fludrocortisone—Convulsion—Paclitaxel—kidney cancer	0.000851	0.00143	CcSEcCtD
Fludrocortisone—Affect lability—Doxorubicin—kidney cancer	0.000849	0.00142	CcSEcCtD
Fludrocortisone—Hypertension—Paclitaxel—kidney cancer	0.000848	0.00142	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—HARS—kidney cancer	0.000838	0.00954	CbGpPWpGaD
Fludrocortisone—Myalgia—Paclitaxel—kidney cancer	0.000836	0.0014	CcSEcCtD
Fludrocortisone—Hypersensitivity—Dactinomycin—kidney cancer	0.000832	0.00139	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—RAF1—kidney cancer	0.000832	0.00948	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—KDR—kidney cancer	0.000825	0.0094	CbGpPWpGaD
Fludrocortisone—Mood swings—Doxorubicin—kidney cancer	0.000818	0.00137	CcSEcCtD
Fludrocortisone—Asthenia—Dactinomycin—kidney cancer	0.000811	0.00136	CcSEcCtD
Fludrocortisone—Erythema—Capecitabine—kidney cancer	0.000806	0.00135	CcSEcCtD
Fludrocortisone—Oedema—Paclitaxel—kidney cancer	0.000802	0.00134	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Paclitaxel—kidney cancer	0.000802	0.00134	CcSEcCtD
Fludrocortisone—Infection—Paclitaxel—kidney cancer	0.000797	0.00133	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL13—kidney cancer	0.000795	0.00906	CbGpPWpGaD
Fludrocortisone—Headache—Sorafenib—kidney cancer	0.000777	0.0013	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Paclitaxel—kidney cancer	0.000775	0.0013	CcSEcCtD
Fludrocortisone—Muscular weakness—Doxorubicin—kidney cancer	0.000761	0.00128	CcSEcCtD
Fludrocortisone—Abdominal distension—Doxorubicin—kidney cancer	0.000751	0.00126	CcSEcCtD
Fludrocortisone—Headache—Sunitinib—kidney cancer	0.000748	0.00125	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.000746	0.0085	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Vincristine—kidney cancer	0.000744	0.00125	CcSEcCtD
Fludrocortisone—Pancreatitis—Doxorubicin—kidney cancer	0.000731	0.00123	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—JUNB—kidney cancer	0.000731	0.00833	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000731	0.00122	CcSEcCtD
Fludrocortisone—Insomnia—Paclitaxel—kidney cancer	0.000725	0.00122	CcSEcCtD
Fludrocortisone—Vertigo—Capecitabine—kidney cancer	0.000724	0.00121	CcSEcCtD
Fludrocortisone—Asthenia—Vincristine—kidney cancer	0.000724	0.00121	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—EIF5B—kidney cancer	0.000712	0.00811	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—kidney cancer	0.000698	0.00795	CbGpPWpGaD
Fludrocortisone—Hypertension—Capecitabine—kidney cancer	0.000696	0.00117	CcSEcCtD
Fludrocortisone—Megestrol acetate—ABCB1—kidney cancer	0.000693	0.037	CrCbGaD
Fludrocortisone—Asthenia—Gemcitabine—kidney cancer	0.000687	0.00115	CcSEcCtD
Fludrocortisone—Myalgia—Capecitabine—kidney cancer	0.000686	0.00115	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—EGR1—kidney cancer	0.000684	0.00779	CbGpPWpGaD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—kidney cancer	0.000673	0.00767	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Doxorubicin—kidney cancer	0.000673	0.00113	CcSEcCtD
Fludrocortisone—Oedema—Capecitabine—kidney cancer	0.000658	0.0011	CcSEcCtD
Fludrocortisone—Infection—Capecitabine—kidney cancer	0.000654	0.0011	CcSEcCtD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—kidney cancer	0.00064	0.00729	CbGpPWpGaD
Fludrocortisone—Urticaria—Paclitaxel—kidney cancer	0.000637	0.00107	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Capecitabine—kidney cancer	0.000636	0.00107	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000635	0.00723	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000635	0.00723	CbGpPWpGaD
Fludrocortisone—Headache—Vincristine—kidney cancer	0.000632	0.00106	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL13—kidney cancer	0.000627	0.00714	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—EGR1—kidney cancer	0.000603	0.00686	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000602	0.00685	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Doxorubicin—kidney cancer	0.0006	0.00101	CcSEcCtD
Fludrocortisone—Headache—Gemcitabine—kidney cancer	0.0006	0.00101	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—MAPK3—kidney cancer	0.0006	0.00683	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000599	0.001	CcSEcCtD
Fludrocortisone—Haemorrhage—Doxorubicin—kidney cancer	0.000597	0.001	CcSEcCtD
Fludrocortisone—Insomnia—Capecitabine—kidney cancer	0.000595	0.000997	CcSEcCtD
Fludrocortisone—Hypersensitivity—Paclitaxel—kidney cancer	0.000591	0.00099	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—CD4—kidney cancer	0.000581	0.00662	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ANXA1—kidney cancer	0.00058	0.00661	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TSC1—kidney cancer	0.00058	0.00661	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—HIF1A—kidney cancer	0.000577	0.00657	CbGpPWpGaD
Fludrocortisone—AR—FOXA1 transcription factor network—CDKN1B—kidney cancer	0.000576	0.00656	CbGpPWpGaD
Fludrocortisone—Asthenia—Paclitaxel—kidney cancer	0.000575	0.000964	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—MAPK1—kidney cancer	0.000571	0.0065	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.000566	0.00645	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AURKA—kidney cancer	0.000565	0.00643	CbGpPWpGaD
Fludrocortisone—AR—FOXA1 transcription factor network—JUN—kidney cancer	0.000548	0.00625	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—CDKN1B—kidney cancer	0.000546	0.00622	CbGpPWpGaD
Fludrocortisone—Methylprednisolone—ABCB1—kidney cancer	0.000531	0.0283	CrCbGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—kidney cancer	0.00053	0.00603	CbGpPWpGaD
Fludrocortisone—Triamcinolone—PTGS2—kidney cancer	0.000527	0.0281	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000523	0.00596	CbGpPWpGaD
Fludrocortisone—Urticaria—Capecitabine—kidney cancer	0.000523	0.000876	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PAK1—kidney cancer	0.000521	0.00593	CbGpPWpGaD
Fludrocortisone—Erythema—Doxorubicin—kidney cancer	0.00052	0.000871	CcSEcCtD
Fludrocortisone—Headache—Paclitaxel—kidney cancer	0.000502	0.000842	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CDKN2A—kidney cancer	0.000501	0.0057	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—kidney cancer	0.000497	0.00566	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—PIK3CA—kidney cancer	0.000495	0.00564	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Capecitabine—kidney cancer	0.000485	0.000812	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000481	0.00548	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—HIF1A—kidney cancer	0.000476	0.00542	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL13—kidney cancer	0.000475	0.00541	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000475	0.00541	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—JUN—kidney cancer	0.000473	0.00538	CbGpPWpGaD
Fludrocortisone—Asthenia—Capecitabine—kidney cancer	0.000472	0.000791	CcSEcCtD
Fludrocortisone—Vertigo—Doxorubicin—kidney cancer	0.000467	0.000782	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—JUNB—kidney cancer	0.000462	0.00526	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—EEF2—kidney cancer	0.000459	0.00523	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—kidney cancer	0.000457	0.0052	CbGpPWpGaD
Fludrocortisone—Convulsion—Doxorubicin—kidney cancer	0.00045	0.000754	CcSEcCtD
Fludrocortisone—Hypertension—Doxorubicin—kidney cancer	0.000449	0.000752	CcSEcCtD
Fludrocortisone—Myalgia—Doxorubicin—kidney cancer	0.000442	0.000741	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—TET2—kidney cancer	0.00044	0.00501	CbGpPWpGaD
Fludrocortisone—Progesterone—CYP1A1—kidney cancer	0.000439	0.0234	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000432	0.00492	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000432	0.00492	CbGpPWpGaD
Fludrocortisone—Betamethasone—PTGS2—kidney cancer	0.000431	0.023	CrCbGaD
Fludrocortisone—Spironolactone—ABCB1—kidney cancer	0.000431	0.023	CrCbGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—APC—kidney cancer	0.000429	0.00489	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BRCA2—kidney cancer	0.000428	0.00487	CbGpPWpGaD
Fludrocortisone—Oedema—Doxorubicin—kidney cancer	0.000424	0.000711	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Doxorubicin—kidney cancer	0.000424	0.000711	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CCND1—kidney cancer	0.000423	0.00482	CbGpPWpGaD
Fludrocortisone—Infection—Doxorubicin—kidney cancer	0.000421	0.000706	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CTNNB1—kidney cancer	0.000419	0.00477	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP1A1—kidney cancer	0.000415	0.0221	CrCbGaD
Fludrocortisone—Headache—Capecitabine—kidney cancer	0.000412	0.000691	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Doxorubicin—kidney cancer	0.00041	0.000687	CcSEcCtD
Fludrocortisone—Prednisone—ABCB1—kidney cancer	0.000406	0.0217	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000404	0.0046	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—kidney cancer	0.000403	0.00459	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—TCEB2—kidney cancer	0.000402	0.00458	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—TCEB1—kidney cancer	0.000402	0.00458	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP1A1—kidney cancer	0.000402	0.0214	CrCbGaD
Fludrocortisone—AR—Gene Expression—HARS—kidney cancer	0.000389	0.00443	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000386	0.000647	CcSEcCtD
Fludrocortisone—Insomnia—Doxorubicin—kidney cancer	0.000384	0.000643	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000376	0.00429	CbGpPWpGaD
Fludrocortisone—Prednisolone—ABCB1—kidney cancer	0.000374	0.02	CrCbGaD
Fludrocortisone—Betamethasone—ABCB1—kidney cancer	0.000367	0.0196	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.00036	0.0041	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—JUN—kidney cancer	0.000358	0.00408	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—RELA—kidney cancer	0.000356	0.00406	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000355	0.00404	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—POMC—kidney cancer	0.000352	0.004	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000351	0.004	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000343	0.00391	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—kidney cancer	0.000341	0.00388	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN2A—kidney cancer	0.00034	0.00388	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—kidney cancer	0.00034	0.00387	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TSC2—kidney cancer	0.000338	0.00385	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—kidney cancer	0.000337	0.00384	CbGpPWpGaD
Fludrocortisone—Urticaria—Doxorubicin—kidney cancer	0.000337	0.000565	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	0.000337	0.00383	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—EIF5B—kidney cancer	0.000331	0.00376	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.00033	0.00376	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—RPL14—kidney cancer	0.000327	0.00373	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CCND1—kidney cancer	0.000313	0.00356	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Doxorubicin—kidney cancer	0.000312	0.000524	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—JUN—kidney cancer	0.000312	0.00355	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CTNNB1—kidney cancer	0.00031	0.00353	CbGpPWpGaD
Fludrocortisone—Asthenia—Doxorubicin—kidney cancer	0.000304	0.00051	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—PTEN—kidney cancer	0.000302	0.00344	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN1B—kidney cancer	0.000301	0.00343	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL2—kidney cancer	0.000295	0.00336	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HARS—kidney cancer	0.000295	0.00336	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—CTNNB1—kidney cancer	0.000291	0.00332	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—HIF1A—kidney cancer	0.00029	0.0033	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—RELA—kidney cancer	0.000289	0.00329	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCND1—kidney cancer	0.000288	0.00328	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—JUN—kidney cancer	0.000287	0.00327	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—ABCB1—kidney cancer	0.000286	0.0153	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CTNNB1—kidney cancer	0.000285	0.00324	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BRAF—kidney cancer	0.000281	0.0032	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PTEN—kidney cancer	0.000278	0.00316	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDH1—kidney cancer	0.000275	0.00313	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—kidney cancer	0.000273	0.00311	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	0.000271	0.00308	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—HSPB1—kidney cancer	0.000267	0.00304	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—EIF4EBP1—kidney cancer	0.000267	0.00304	CbGpPWpGaD
Fludrocortisone—Headache—Doxorubicin—kidney cancer	0.000266	0.000445	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—kidney cancer	0.00026	0.00296	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	0.000255	0.00291	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—JUN—kidney cancer	0.000253	0.00288	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PTGS2—kidney cancer	0.000251	0.0134	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—EIF5B—kidney cancer	0.000251	0.00286	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000251	0.00285	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PSMD7—kidney cancer	0.000248	0.00282	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000248	0.00282	CbGpPWpGaD
Fludrocortisone—Progesterone—ABCB1—kidney cancer	0.000233	0.0124	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYC—kidney cancer	0.000231	0.00263	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MTOR—kidney cancer	0.000229	0.00261	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—JUNB—kidney cancer	0.000223	0.00253	CbGpPWpGaD
Fludrocortisone—Testosterone—ABCB1—kidney cancer	0.000221	0.0118	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—JUNB—kidney cancer	0.000214	0.00244	CbGpPWpGaD
Fludrocortisone—Dexamethasone—ABCB1—kidney cancer	0.000213	0.0114	CrCbGaD
Fludrocortisone—AR—Gene Expression—EEF2—kidney cancer	0.000213	0.00243	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—kidney cancer	0.000209	0.00238	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	0.000205	0.00234	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CCND1—kidney cancer	0.000205	0.00233	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—JUN—kidney cancer	0.000204	0.00233	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—TET2—kidney cancer	0.000204	0.00233	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	0.000203	0.00231	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000199	0.00227	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—kidney cancer	0.000199	0.00226	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PTEN—kidney cancer	0.000198	0.00225	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000198	0.00225	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000194	0.00221	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000192	0.00219	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—kidney cancer	0.000189	0.00216	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000188	0.00214	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—TCEB2—kidney cancer	0.000187	0.00213	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—TCEB1—kidney cancer	0.000187	0.00213	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—CDKN2B—kidney cancer	0.000181	0.00206	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	0.000179	0.00203	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000178	0.00203	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000175	0.00199	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000174	0.00198	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CTNNB1—kidney cancer	0.000174	0.00198	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.00017	0.00193	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000169	0.00193	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000168	0.00192	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—kidney cancer	0.000167	0.0019	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MYC—kidney cancer	0.000164	0.00187	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000164	0.00187	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—JUNB—kidney cancer	0.000163	0.00185	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—EEF2—kidney cancer	0.000162	0.00184	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	0.000161	0.00183	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—TET2—kidney cancer	0.000155	0.00176	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—KRAS—kidney cancer	0.000152	0.00173	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RPL14—kidney cancer	0.000152	0.00173	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000151	0.00172	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.00015	0.00171	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000148	0.00169	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MYC—kidney cancer	0.000146	0.00166	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—TCEB1—kidney cancer	0.000142	0.00161	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—TCEB2—kidney cancer	0.000142	0.00161	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.00014	0.00159	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000136	0.00155	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—kidney cancer	0.000135	0.00154	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000133	0.00152	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000132	0.00151	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000132	0.0015	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.000126	0.00143	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—EIF4EBP1—kidney cancer	0.000124	0.00141	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HSPB1—kidney cancer	0.000124	0.00141	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	0.000116	0.00132	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—RPL14—kidney cancer	0.000115	0.00131	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PSMD7—kidney cancer	0.000115	0.00131	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.000112	0.00127	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—JUNB—kidney cancer	0.000103	0.00118	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HSPB1—kidney cancer	9.39e-05	0.00107	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	9.39e-05	0.00107	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PSMD7—kidney cancer	8.73e-05	0.000994	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CDKN2B—kidney cancer	8.4e-05	0.000957	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—JUNB—kidney cancer	7.83e-05	0.000892	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MAPK3—kidney cancer	7.22e-05	0.000822	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MYC—kidney cancer	7.02e-05	0.0008	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MYC—kidney cancer	6.77e-05	0.000771	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CDKN2B—kidney cancer	6.38e-05	0.000726	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	5.13e-05	0.000585	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MAPK3—kidney cancer	3.35e-05	0.000381	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MYC—kidney cancer	3.26e-05	0.000371	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MAPK3—kidney cancer	2.54e-05	0.000289	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MYC—kidney cancer	2.47e-05	0.000281	CbGpPWpGaD
